# Pyxis Oncology, Inc.: filings

PYXS · Nasdaq · CIK 1782223 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pyxs.md) · [Financials](/companies/pyxs/financials.md) · [Filings](/companies/pyxs/filings.md) · [Insiders](/companies/pyxs/insiders.md)

## Reports and events: 96 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 100, 8-K 56, 144 19, 3 19, 10-Q 15, 425 9, S-8 9, SC 13G/A 9, CORRESP 8, SC 13G 8, SCHEDULE 13G/A 8, DEF 14A 7, EFFECT 7, UPLOAD 7, 10-K 5, DEFA14A 5, SCHEDULE 13G 5, S-3 4, 424B5 3, ARS 3, S-1/A 3, SC 13D/A 3, 424B2 2, 8-K/A 2, D 2, DRS/A 2, DRSLTR 2, PRE 14A 2, SCHEDULE 13D/A 2, SEC STAFF LETTER 2, 10-K/A 1, 144/A 1, 424B3 1, 424B4 1, 4/A 1, 8-A12B 1, CERT 1, DRS 1, POS AM 1, S-1 1, S-1MEF 1, S-4 1, S-4/A 1, S-8 POS 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-21 | 20:27 ET | [DEF 14A](/filings/0001193125-26-427882.md) | Proxy statement, period 2026-10-21 | 0001193125-26-427882 |
| 2026-10-01 | 21:24 ET | [8-K](/filings/0001437749-26-031767.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-031767 |
| 2026-09-09 | 11:34 ET | [8-K](/filings/0001193125-26-385901.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-385901 |
| 2026-09-08 | 11:39 ET | [8-K](/filings/0001193125-26-384386.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-384386 |
| 2026-08-13 | 11:44 ET | [10-Q](/filings/0001193125-26-347913.md) | Quarterly report, period 2026-06-30 | 0001193125-26-347913 |
| 2026-08-13 | 11:42 ET | [8-K](/filings/0001193125-26-347911.md) | 2.02 Results of operations | 0001193125-26-347911 |
| 2026-07-02 | 20:20 ET | [8-K](/filings/0001193125-26-294613.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure | 0001193125-26-294613 |
| 2026-06-15 | 20:22 ET | [8-K](/filings/0001193125-26-271137.md) | 5.07 Shareholder vote results | 0001193125-26-271137 |
| 2026-05-14 | 11:56 ET | [10-Q](/filings/0001193125-26-222843.md) | Quarterly report, period 2026-03-31 | 0001193125-26-222843 |
| 2026-05-14 | 11:36 ET | [8-K](/filings/0001193125-26-222818.md) | 2.02 Results of operations | 0001193125-26-222818 |
| 2026-04-30 | 11:35 ET | [DEF 14A](/filings/0001193125-26-194032.md) | Proxy statement, period 2026-04-30 | 0001193125-26-194032 |
| 2026-04-30 | 11:04 ET | [8-K/A](/filings/0001193125-26-193940.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-193940 |
| 2026-03-23 | 11:17 ET | [10-K](/filings/0001193125-26-118532.md) | Annual report, period 2025-12-31 | 0001193125-26-118532 |
| 2026-03-23 | 11:12 ET | [8-K](/filings/0001193125-26-118525.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001193125-26-118525 |
| 2026-02-06 | 21:07 ET | [8-K](/filings/0001193125-26-041169.md) | 9.01 Financial statements and exhibits | 0001193125-26-041169 |
| 2025-12-18 | 12:25 ET | [8-K](/filings/0001193125-25-323704.md) | 7.01 Regulation FD disclosure; 8.01 Other events | 0001193125-25-323704 |
| 2025-11-03 | 12:36 ET | [10-Q](/filings/0001193125-25-261696.md) | Quarterly report, period 2025-09-30 | 0001193125-25-261696 |
| 2025-11-03 | 12:33 ET | [8-K](/filings/0001193125-25-261689.md) | 2.02 Results of operations | 0001193125-25-261689 |
| 2025-08-14 | 20:19 ET | [10-Q](/filings/0000950170-25-108906.md) | Quarterly report, period 2025-06-30 | 0000950170-25-108906 |
| 2025-08-14 | 20:17 ET | [8-K](/filings/0000950170-25-108898.md) | 2.02 Results of operations | 0000950170-25-108898 |
| 2025-08-04 | 11:26 ET | [8-K](/filings/0000950170-25-101618.md) | 8.01 Other events | 0000950170-25-101618 |
| 2025-07-03 | 00:30 ET | [8-K](/filings/0000950170-25-093456.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-093456 |
| 2025-06-18 | 20:17 ET | [8-K](/filings/0000950170-25-087907.md) | 5.07 Shareholder vote results | 0000950170-25-087907 |
| 2025-05-15 | 11:41 ET | [10-Q](/filings/0000950170-25-071996.md) | Quarterly report, period 2025-03-31 | 0000950170-25-071996 |
| 2025-05-15 | 11:35 ET | [8-K](/filings/0000950170-25-071992.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0000950170-25-071992 |
| 2025-04-29 | 11:41 ET | [DEF 14A](/filings/0000950170-25-059573.md) | Proxy statement, period 2025-04-29 | 0000950170-25-059573 |
| 2025-04-02 | 01:25 ET | [SCHEDULE 13D/A](/filings/0000950170-25-049860.md) | Ownership report, active investor, amended | 0000950170-25-049860 |
| 2025-03-24 | 11:43 ET | [8-K](/filings/0000950170-25-043491.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-043491 |
| 2025-03-18 | 12:03 ET | [10-K](/filings/0000950170-25-040771.md) | Annual report, period 2024-12-31 | 0000950170-25-040771 |
| 2025-03-18 | 11:57 ET | [8-K](/filings/0000950170-25-040767.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-040767 |
| 2025-02-26 | 12:39 ET | [8-K](/filings/0000950170-25-027330.md) | 8.01 Other events | 0000950170-25-027330 |
| 2025-02-04 | 12:40 ET | [8-K](/filings/0000950170-25-012846.md) | 8.01 Other events | 0000950170-25-012846 |
| 2024-12-23 | 23:31 ET | [SCHEDULE 13D/A](/filings/0000950170-24-139789.md) | Ownership report, active investor, amended | 0000950170-24-139789 |
| 2024-12-19 | 22:07 ET | [8-K](/filings/0000950170-24-138563.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-138563 |
| 2024-11-20 | 21:06 ET | [8-K](/filings/0000950170-24-129238.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-129238 |
| 2024-11-12 | 12:43 ET | [10-Q](/filings/0000950170-24-124602.md) | Quarterly report, period 2024-09-30 | 0000950170-24-124602 |
| 2024-11-12 | 12:34 ET | [8-K](/filings/0000950170-24-124581.md) | 2.02 Results of operations | 0000950170-24-124581 |
| 2024-10-23 | 20:53 ET | [8-K](/filings/0000950170-24-116698.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-116698 |
| 2024-09-25 | 20:08 ET | [DEF 14A](/filings/0000950170-24-109337.md) | Proxy statement, period 2024-09-25 | 0000950170-24-109337 |
| 2024-08-14 | 20:25 ET | [10-Q](/filings/0000950170-24-097073.md) | Quarterly report, period 2024-06-30 | 0000950170-24-097073 |
| 2024-08-14 | 20:19 ET | [8-K](/filings/0000950170-24-097054.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-097054 |
| 2024-06-12 | 20:17 ET | [8-K](/filings/0000950170-24-072467.md) | 5.07 Shareholder vote results | 0000950170-24-072467 |
| 2024-06-10 | 11:56 ET | [8-K](/filings/0001193125-24-157911.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-157911 |
| 2024-05-14 | 12:00 ET | [10-Q](/filings/0000950170-24-059099.md) | Quarterly report, period 2024-03-31 | 0000950170-24-059099 |
| 2024-05-14 | 11:55 ET | [8-K](/filings/0000950170-24-059093.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-059093 |
| 2024-04-26 | 20:15 ET | [DEF 14A](/filings/0000950170-24-049154.md) | Proxy statement, period 2024-06-11 | 0000950170-24-049154 |
| 2024-04-03 | 21:10 ET | [SC 13D/A](/filings/0000950170-24-041264.md) | Ownership report, active investor, amended | 0000950170-24-041264 |
| 2024-03-27 | 20:09 ET | [8-K](/filings/0000950170-24-037176.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-037176 |
| 2024-03-27 | 11:49 ET | [8-K](/filings/0000950170-24-036822.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-036822 |
| 2024-03-21 | 21:11 ET | [10-K](/filings/0000950170-24-034868.md) | Annual report, period 2023-12-31 | 0000950170-24-034868 |

Page 1 of 2. [Older](/companies/pyxs/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.